Esperante
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
37-41 Mortimer St, London, Greater Londo...Website
www.esperante.comRevenue
<$5 MillionIndustry
About Esperante
Is Esperante your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Esperante recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Esperante
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Esperante has new funding data
Check if Esperante has recently received funding, and reach out quickly before it becomes old news!
Click to see if Esperante had a recent Job posting/layoffs
Product Launch: Get notified when Esperante launches new products
Check out if Esperante is spiking on competitors!
Esperante, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Esperante
Find 3 more new buyers
Compare Similar Companies to Esperante
Compare insights from companies similar to Esperante, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Esperante
Esperante Tech Stack
A closer look at the technologies used by Esperante
Esperante News & Media
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Esperante
Esperante is a corporate venture investment company that specializes in innovative life science investments, focusing on mid to late stage clinical therapeutics development companies in North America and Europe. Backed by a pharmaceutical industry family, it is managed by a team with extensive experience in pharma and diagnostics. The firm invests... Read More